108 related articles for article (PubMed ID: 23039140)
1. Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels.
Fukuda H; Suzuki T; Saotome A; Sode E; Mukai H
J Dermatol; 2013 Jan; 40(1):43-7. PubMed ID: 23039140
[TBL] [Abstract][Full Text] [Related]
2. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
[TBL] [Abstract][Full Text] [Related]
3. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
4. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
5. Topical clofibrate improves symptoms in patients with atopic dermatitis and reduces serum TARC levels: a randomized, double-blind, placebo-controlled pilot study.
Fukaya M; Kimata H
J Drugs Dermatol; 2014 Mar; 13(3):259-63. PubMed ID: 24595568
[TBL] [Abstract][Full Text] [Related]
6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
7. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
[TBL] [Abstract][Full Text] [Related]
8. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.
Kataoka Y
J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072
[TBL] [Abstract][Full Text] [Related]
9. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
Gu CY; Gu L; Dou X
Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
[TBL] [Abstract][Full Text] [Related]
11. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments.
Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342
[TBL] [Abstract][Full Text] [Related]
12. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical function in patients with severe atopic dermatitis.
Matsuda K; Katsunuma T; Iikura Y; Kato H; Saito H; Akasawa A
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):35-9. PubMed ID: 10923602
[TBL] [Abstract][Full Text] [Related]
14. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
15. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis.
Gohar MK; Atta AH; Nasr MM; Hussein DN
Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575
[TBL] [Abstract][Full Text] [Related]
16. Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab.
Mizuno M; Horiguchi G; Teramukai S; Ichiyama S; Ito M; Hoashi T; Kanda N; Saeki H
Australas J Dermatol; 2021 Nov; 62(4):e504-e509. PubMed ID: 34523731
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.
Landheer J; de Bruin-Weller M; Boonacker C; Hijnen D; Bruijnzeel-Koomen C; Röckmann H
J Am Acad Dermatol; 2014 Dec; 71(6):1160-6. PubMed ID: 25199679
[TBL] [Abstract][Full Text] [Related]
18. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
20. Cortisol and adrenocorticotropic hormone dynamics in the acute phase of subarachnoid haemorrhage.
Zetterling M; Engström BE; Hallberg L; Hillered L; Enblad P; Karlsson T; Ronne Engström E
Br J Neurosurg; 2011 Dec; 25(6):684-92. PubMed ID: 22115015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]